The study of ocular infections and immune responses is critical in managing vision-threatening conditions. Ocular microbiology and immunology focus on pathogens like bacteria, viruses, and fungi that cause conjunctivitis, keratitis, and endophthalmitis. Understanding the eye’s immune privilege is vital for developing targeted therapies that minimize inflammation while combating infection. Recent research highlights the role of the ocular microbiome in maintaining homeostasis and its disruption in disease states. Advances in molecular diagnostics, such as PCR-based assays, enable rapid identification of pathogens, improving treatment precision. Immunomodulatory therapies, including biologics, are emerging as effective options for uveitis and other inflammatory disorders. These insights guide clinicians in optimizing antimicrobial and immunosuppressive strategies, ensuring better prognosis for patients with complex ocular conditions.
Title : Rare and interesting case of Goldenhar’s syndrome in a 3 years old male child
Gowhar Ahmad, Florence Hospital Srinagar, India
Title : Management of common vitreoretinal lesions: An overview and update
Tim Jackson, King’s College London, United Kingdom
Title : Targeting immunological pathways in Behcet's uveitis
Hashim Butt, Bolton Royal Hospital, United Kingdom
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : The effect of low hypermetropia correction and office-based orthoptic training on binocular vision parameters in children with convergence insufficiency
Agnieszka Rosa, Orticus Center for the Treatment of Strabismus and Vision Disorders, Poland
Title : Evaluating the quality and readability of AI chatbot responses to frequently asked questions on basal cell carcinoma: Implications for patient education and digital health communication
Arrane Selvamogan, Leicestershire Partnership NHS Trust, United Kingdom